We are live on
!
Find out more
Harmony Biosciences
HRMY
HRMY
309 hedge funds and large institutions have $1.57B invested in Harmony Biosciences in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 132 increasing their positions, 96 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 96
9.97% more ownership
Funds ownership: 86.62% → 96.59% (+10%)
4% less funds holding
Funds holding: 323 → 309 (-14)
12% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 50
16% less capital invested
Capital invested by funds: $1.87B → $1.57B (-$301M)
38% less call options, than puts
Call options by funds: $12.4M | Put options by funds: $20.1M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
309
Holders Change
-14
Holders Change %
-4.33%
% of All Funds
3.8%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
44
Increased
132
Reduced
96
Closed
50
Calls
$12.4M
Puts
$20.1M
Net Calls
-$7.63M
Net Calls Change
-$11.8M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$36.9M |
| 2 |
SG Americas Securities
New York
|
+$34.6M |
| 3 |
Millennium Management
New York
|
+$23.7M |
| 4 |
Goldman Sachs
New York
|
+$22M |
| 5 |
JP Morgan Chase
New York
|
+$20.5M |
